These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11871493)

  • 1. Immunotherapy of sepsis.
    van der Poll T
    Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.
    Skirecki T; Borkowska-Zielińska U; Złotorowicz M; Hoser G
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):123-35. PubMed ID: 22301668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating strategies in the treatment of sepsis].
    Schultz MJ; van der Poll T
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2530-3. PubMed ID: 12532664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we be moving from suppression to stimulation to deal with immunoparalysis in sepsis patients?
    Giamarellos-Bourboulis EJ
    Immunotherapy; 2014; 6(2):113-5. PubMed ID: 24491083
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy in the prophylaxis and treatment of neonatal sepsis.
    Suri M; Harrison L; Van de Ven C; Cairo MS
    Curr Opin Pediatr; 2003 Apr; 15(2):155-60. PubMed ID: 12640271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis.
    Nelson S; Bagby GJ
    Clin Chest Med; 1996 Jun; 17(2):319-32. PubMed ID: 8792069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections.
    Norrby-Teglund A; Ihendyane N; Darenberg J
    Scand J Infect Dis; 2003; 35(9):683-9. PubMed ID: 14620155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis.
    Tuttle K; McDonald M; Anderson E
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological therapy in sepsis: currently available.
    Carlet J;
    Intensive Care Med; 2001; 27 Suppl 1():S93-103. PubMed ID: 11307373
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor as the expecting sword for the treatment of severe sepsis.
    Murata A
    Curr Pharm Des; 2003; 9(14):1115-20. PubMed ID: 12769751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the therapy for sepsis in children.
    Anderson MR; Blumer JL
    Pediatr Clin North Am; 1997 Feb; 44(1):179-205. PubMed ID: 9057790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
    Prucha M; Zazula R; Russwurm S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant anticoagulant factors for adjunctive treatment of sepsis.
    Levi M; Lowenberg E; Meijers JC
    Semin Thromb Hemost; 2010 Jul; 36(5):550-7. PubMed ID: 20632252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation and sepsis.
    Karzai W; Reinhart K
    Int J Clin Pract; 1997 Jun; 51(4):232-7. PubMed ID: 9287265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins in neonatal sepsis: has the final word been said?
    Capasso L; Borrelli AC; Ferrara T; Coppola C; Cerullo J; Izzo F; Caiazza R; Lama S; Raimondi F
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S47-9. PubMed ID: 25220128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Such stuff as dreams are made on: mediator-directed therapy in sepsis.
    Marshall JC
    Nat Rev Drug Discov; 2003 May; 2(5):391-405. PubMed ID: 12750742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of immunomodulatory therapy initiation for sepsis].
    Karzai W; Gramm HJ; Reinhart K
    Dtsch Med Wochenschr; 1998 Jul; 123(31-32):948-52. PubMed ID: 9721572
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit?
    Brown KA; Brown GA; Lewis SM; Beale R; Treacher DF
    Int Immunopharmacol; 2016 Jul; 36():291-299. PubMed ID: 27208433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.